Content Status
Type
Linked Node
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB
Learning Objectives-
Describe the methods used under the NTEP to ensure the reliability of Drug-resistant Tuberculosis (DR-TB) diagnostic tests:
a) Quality Assurance (QA) and control of tests
b) Proficiency testing
-
The National Tuberculosis Elimination Program (NTEP) uses the following methods to ensure the reliability of Drug-resistant Tuberculosis (DR-TB) diagnostic tests:
- Quality Assurance (QA) and control of tests
- Proficiency testing
Quality Assurance and Control of Tests
NTEP has a well-established quality assurance mechanism which follows the WHO system of hierarchical control from the highest level of National Reference laboratories to State Intermediate Reference laboratories, to the district/sub district level and then, TB diagnostic centres at the most peripheral level.
The QA has all elements of Internal Quality Control (IQC), On-site Evaluation (OSE) and External Quality Control (EQC).
QA ACTIVITIES FOR DR-TB DIAGNOSTIC TESTS |
COMPONENTS OF QA |
---|---|
External QA (EQA) for sputum smear microscopy |
On-site evaluation, panel testing and Random Blinded Rechecking (RBRC) |
Culture and Drug Susceptibility Testing (C&DST) |
IQC and EQA mechanisms |
IQC of Lowenstein Jensen (LJ) media |
Testing each batch of media for contamination as well as the use of control strain (H37RV) for growth parameters |
IQC for Mycobacteria Growth Indicator Tube (MGIT) |
Instrument guided |
IQC of DST |
Involves use of control strain (H37RV) as well as mono-resistant strains with every batch of DST performed |
EQA for DST |
Done through structured panel testing and retesting exercises |
Proficiency Testing
- Proficiency testing (PT) is the measure used to examine the proficiency of the technician/professional performing the test to conduct it. Annual PTs ensure that the technicians/professionals are performing the tests as intended and their proficiency is satisfactory.
- PT exercise is conducted annually to certify laboratories in all technologies used for determination of drug resistance.
- PT for line-probe assay (LPA) includes benchmarks for invalid results, contamination in negative control, internal and external concordance.
- PT is also conducted for phenotypic DST, Cartridge-based Nucleic Acid Amplification Tests (CBNAAT) (internal and external controls) and TrueNat tests.
- Coordination of external quality assurance activity, manufacture and validation of the panels is undertaken by National TB Institute, Bangalore.
Resources
Kindly provide your valuable feedback on the page to the link provided HERE
Content Creator
Reviewer
- Log in to post comments